Revolution Medicines, Inc.
RVMD
$77.03
$1.722.28%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -305.21M | -247.79M | -213.42M | -194.57M | -156.29M |
| Total Depreciation and Amortization | 4.04M | 3.60M | 3.42M | 3.09M | 2.58M |
| Total Amortization of Deferred Charges | 300.00K | 200.00K | 300.00K | 300.00K | 300.00K |
| Total Other Non-Cash Items | 37.11M | 26.53M | 12.83M | 10.87M | 12.65M |
| Change in Net Operating Assets | 56.44M | -4.30M | 2.44M | 42.02M | 10.34M |
| Cash from Operations | -207.31M | -221.76M | -194.44M | -138.29M | -130.42M |
| Capital Expenditure | -3.35M | -7.45M | -3.27M | -1.22M | -3.52M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 28.20M | 41.73M | -12.68M | -391.68M | -17.95M |
| Cash from Investing | 24.85M | 34.28M | -15.95M | -392.90M | -21.47M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.15M | 6.58M | 892.00K | 778.10M | 77.29M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.74M | 250.00M | -18.00K | 95.71M | -- |
| Cash from Financing | -1.59M | 256.58M | 874.00K | 873.81M | 77.29M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -184.05M | 69.10M | -209.51M | 342.61M | -74.59M |